Lipid complexes of amphotericin B: the competitive picture.
Richardson
M D
MD
D000666:Amphotericin B / Q000009:adverse effects / Q000031:analogs & derivatives / Q000737:chemistry* / Q000627:therapeutic use; D000818:Animals; D000935:Antifungal Agents / Q000009:adverse effects / Q000737:chemistry* / Q000627:therapeutic use; D002788:Cholesterol Esters / Q000737:chemistry / Q000627:therapeutic use; D004338:Drug Combinations; D006801:Humans; D009181:Mycoses / Q000188:drug therapy* / Q000473:pathology; D010713:Phosphatidylcholines / Q000737:chemistry / Q000627:therapeutic use; D010715:Phosphatidylglycerols / Q000737:chemistry / Q000627:therapeutic use
D000935:Antifungal Agents; D002788:Cholesterol Esters; D004338:Drug Combinations; D010713:Phosphatidylcholines; D010715:Phosphatidylglycerols; C068538:liposomal amphotericin B; D000666:Amphotericin B